Pharmacoeconomic benefit of antibiotic step-down therapy: converting patients from intravenous ceftriaxone to oral cefpodoxime proxetil.

@article{Hendrickson1995PharmacoeconomicBO,
  title={Pharmacoeconomic benefit of antibiotic step-down therapy: converting patients from intravenous ceftriaxone to oral cefpodoxime proxetil.},
  author={J R Hendrickson and Donald S. North},
  journal={The Annals of pharmacotherapy},
  year={1995},
  volume={29 6},
  pages={561-5}
}
OBJECTIVE To evaluate the economic benefit associated with the early conversion of therapy from intravenous ceftiaxone to the comparable oral third-generation cephalosporin, cefpodoxime proxetil. DESIGN Open-label, unblind, nonrandomized clinical trial. SETTING A 360-bed Veterans Affairs Medical Center. PATIENTS Forty patients who began receiving… CONTINUE READING